Cargando…
Overexpression of p65 attenuates celecoxib-induced cell death in MDA-MB-231 human breast cancer cell line
BACKGROUND: Celecoxib is a selective cyclooxygenase (COX)-2 inhibitor that has been reported to reduce the risk of breast cancer. In our previous study, celecoxib induced apoptosis and caused cell cycle arrest at the G0/G1 phase in the breast cancer cell line MDA-MB-231, and its effects were mediate...
Autores principales: | Wang, Ling, Kang, Fubiao, Li, Jie, Zhang, Jing, Shan, Baoen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3586361/ https://www.ncbi.nlm.nih.gov/pubmed/23402310 http://dx.doi.org/10.1186/1475-2867-13-14 |
Ejemplares similares
-
Neuropeptide-induced modulation of carcinogenesis in a metastatic breast cancer cell line (MDA-MB-231(LUC+))
por: Gutierrez, Silvia, et al.
Publicado: (2018) -
Antitumor activity of arsenite in combination with tetrandrine against human breast cancer cell line MDA-MB-231 in vitro and in vivo
por: Yuan, Bo, et al.
Publicado: (2018) -
Avenanthramide-C reduces the viability of MDA-MB-231 breast cancer cells through an apoptotic mechanism
por: Hastings, Jordan, et al.
Publicado: (2017) -
Human cytomegalovirus interleukin-10 enhances matrigel invasion of MDA-MB-231 breast cancer cells
por: Valle Oseguera, Cendy A., et al.
Publicado: (2017) -
ETS1 is associated with cisplatin resistance through IKKα/NF-κB pathway in cell line MDA-MB-231
por: Zhang, Yuzhu, et al.
Publicado: (2018)